Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling. Cavalleri, L., Merlo Pich, E., Millan, M., J., Chiamulera, C., Kunath, T., Spano, P., F., & Collo, G. Molecular Psychiatry, 23(4):812-823, Nature Publishing Group, 11, 2018.
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling [pdf]Paper  Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling [link]Website  abstract   bibtex   
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling

Downloads: 0